We are live on ! Find out more
LPCN icon

Lipocine
LPCN

16 hedge funds and large institutions have $22.2M invested in Lipocine in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+16
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JHIU
Janus Henderson Investors US
Colorado
+$5.93M
2
BBA
Baker Bros. Advisors
New York
+$3.52M
3
TCP
Tourbillon Capital Partners
New York
+$3.17M
4
SM
Sabby Management
Florida
+$2.93M
5
LOAMU
Lombard Odier Asset Management (USA)
New York
+$2.74M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JHIU
1
Janus Henderson Investors US
Colorado
$5.14M +$5.93M +49,577 New
BBA
2
Baker Bros. Advisors
New York
$3.05M +$3.52M +29,412 New
TCP
3
Tourbillon Capital Partners
New York
$2.75M +$3.17M +26,471 New
SM
4
Sabby Management
Florida
$2.54M +$2.93M +24,512 New
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$2.38M +$2.74M +22,941 New
DMAM
6
Del Mar Asset Management
New York
$2.03M +$2.34M +19,608 New
BC
7
Broadfin Capital
New York
$1.61M +$1.86M +15,561 New
WC
8
Wexford Capital
Florida
$1.14M +$1.31M +10,941 New
VM
9
VHCP Management
New York
$867K +$1,000K +8,359 New
PCM
10
Prelude Capital Management
New York
$371K +$428K +3,577 New
ISL
11
Ingalls & Snyder LLC
New York
$243K +$281K +2,346 New
Millennium Management
12
Millennium Management
New York
$72K +$83K +694 New
BIM
13
BlackRock Investment Management
Delaware
$9K +$10.9K +91 New
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$6K +$7.06K +59 New
TRCT
15
Tower Research Capital (TRC)
New York
$5K +$6.1K +51 New
Morgan Stanley
16
Morgan Stanley
New York
– +$120 +1 New

LPCN Hedge Fund Activity: Q2 2014 in Review

16 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q2 2014, worth a combined $22.2M.

Buyers outnumbered sellers: 16 funds opened new LPCN positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $5.93M.

  • 16 institutional investors held Lipocine (LPCN) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $22.2M of Lipocine stock for Q2 2014.
  • 16 funds opened new Lipocine positions in Q2 2014 and 0 closed out, a net change of +16 holders.
  • The largest Lipocine buyer in Q2 2014 was Janus Henderson Investors US, an estimated $5.93M added.

Based on aggregated 13F filings for Q2 2014.